COMMUNIQUÉS West-GlobeNewswire

United States Patent and Trademark Office Issues Composition of Matter Patent with BeyondSpring’s Lead Asset Plinabulin with Protection to 2036

21/12/2018 - 13:30

NEW YORK, Dec. 21, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that the United States Patent [...]

Rockwell Medical, Inc. to Present at Biotech Showcase™ 2019

21/12/2018 - 13:03

WIXOM, Mich., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at Biotech Showcase™ [...]

Surface Oncology Added to the NASDAQ Biotechnology Index

21/12/2018 - 13:00

CAMBRIDGE, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced [...]

Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne

21/12/2018 - 13:00

REHOVOT, Israel and BRIDGEWATER, N.J., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing [...]

Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan

21/12/2018 - 13:00

-Financing Strengthens Cash Position Ahead of Two Potential Product Launches in 2019- DUBLIN, Ireland, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company [...]

Recro Pharma Amends IV Meloxicam License Agreement with Alkermes

21/12/2018 - 13:00

Reduces 2019 Cash Requirements by $30 Million; Extends Approval Milestone Payments Over Seven Years MALVERN, Pa., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty [...]

Loxo Oncology Announces Initiation of Phase 1/2 Clinical Trial for Highly Selective, Non-Covalent BTK Inhibitor, LOXO-305

21/12/2018 - 12:45

STAMFORD, Conn., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company focused on the development and commercialization of highly selective medicines for patients with [...]

Holding(s) in Company

21/12/2018 - 12:30

Holding(s) in Company December 21, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Shire Plc JE00B2QKY057 1b. [...]

ViroGates financial calendar 2019

21/12/2018 - 12:13

Company announcement no. 9-2018 Birkerød, 21 December 2018 ViroGates A/S (Nasdaq First North Denmark: VIRO) has published its financial calendar for 2019 with the following key dates: 20 March Deadline for submission of [...]

HEXO Corp, licensed cannabis company, delivers on commitment to seek a listing on the NYSE

21/12/2018 - 12:00

Application made to list shares on the NYSE American GATINEAU, Quebec, Dec. 21, 2018 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO ), a leading licensed cannabis company based in Canada, is pleased [...]

HEXO Corp, producteur autorisé de cannabis, respecte son engagement à inscrire ses actions au NYSE

21/12/2018 - 12:00

Dépôt d’une demande d’inscription d’actions à la cote du NYSE American GATINEAU, Québec, 21 déc. 2018 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO ), un important producteur autorisé canadien de [...]

Genetic Technologies Limited Provides End of Year Update on the Test Development Program

21/12/2018 - 11:30

MELBOURNE, Australia, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), a diversified molecular diagnostics company embracing blockchain technologies across genomic [...]

Nexstim Plc's Financial Information in 2019

21/12/2018 - 08:01

Company announcement, Helsinki, 21 December 2018 at 09.00 Nexstim Plc's Financial Information in 2019 Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering [...]

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula

21/12/2018 - 08:00

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula Herantis Pharma Plc Company release 21 December 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]

Nicox recentre ses activités de recherche sur de nouveaux composés donneurs de NO inhibiteurs de la PDE-5 pour le glaucome et signature avec Novaliq d'un accord de collaboration

21/12/2018 - 07:31

Communiqué de presse Nicox recentre ses activités de recherche sur de nouveaux composés donneurs de NO inhibiteurs de la PDE-5 pour le glaucome et signe avec Novaliq un accord de collaboration sur des formulations [...]

Nicox Focuses Research Activities on Novel NO-Donating PDE5 Inhibitors for Glaucoma and Enters into Collaboration with Novaliq

21/12/2018 - 07:31

Press Release Nicox Focuses Research Activities on Novel NO-Donating PDE5 Inhibitors for Glaucoma and Enters into Collaboration with Novaliq on Innovative Topical Ophthalmic Formulations [...]

Sensorion Announces Publication of SENS-401 Data in Otology & Neurology Journal

21/12/2018 - 07:30

Improvement of hearing recovery above threshold for clinical relevance when SENS-401 was administered daily for 28 days delayed as much as 96 hrs after acoustic trauma in a preclinical model MONTPELLIER, France, Dec. 21 [...]

Biocartis Group NV: Disclosure of outstanding voting securities

21/12/2018 - 07:01

PRESS RELEASE : REGULATED INFORMATION 21 December 2018, 07:00 CET Disclosure of Outstanding Voting Securities Mechelen, Belgium, 21 December 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]

CROSSJECT : SUCCES DE L'AUGMENTATION DE CAPITAL D'UN MONTANT DE 4 MILLIONS D'EUROS

21/12/2018 - 07:01

Communiqué de Presse SUCCES DE L'AUGMENTATION DE CAPITAL D'UN MONTANT DE 4 MILLIONS D'EUROS Opération intégralement souscrite Règlement livraison des actions nouvelles le 28 décembre 2018 Dijon, le 21 décembre 2018 [...]